Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection

NCT02597166 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C, Chronic
Cirrhosis, Decompensated

Interventions

DRUG: Ledipasvir/Sofosbuvir

Sponsor

University Health Network, Toronto

Collaborators

[object Object]